Insider · CIK 0001370930
Cary J Claiborne
Files at ADIL (ADIAL PHARMACEUTICALS, INC.). First filing -, latest -.
In brief
Cary J Claiborne files SEC Form 4 as CEO and director at ADIL (ADIAL PHARMACEUTICALS, INC.). No open-market trade is on file; the transactions below are grants, exercises and other rows that carry no view on the price.
A track record needs three past buys with six months of prices behind them; Cary J Claiborne has 0, so none is measured yet.
Signals
This insider’s open-market buys and sells, scored.
Transactions
Every row this insider has filed, 3 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Apr 7, 2026 | ADIL ADIAL PHARMACEUTICALS, INC. | AGrant or award Common Stock | +37,985 | $0.00 | $0 | 40,417 | Apr 9, 2026 |
| May 29, 2025 | ADIL ADIAL PHARMACEUTICALS, INC. | AGrant or award Stock Option (Right to Buy)derivative | +138,000 | $0.00 | $0 | 138,000 | Jun 2, 2025 |
| Dec 5, 2024 | ADIL ADIAL PHARMACEUTICALS, INC. | AGrant or award Stock Option (Right to Buy)derivative | +350,000 | $0.00 | $0 | 350,000 | Dec 5, 2024 |
Questions about Cary J Claiborne
Answered from the filings on this page, as of the latest one.
Is Cary J Claiborne buying or selling?
Cary J Claiborne has no open-market buy or sell on SEC Form 4; the filings on record are grants, exercises and other transactions.
How did Cary J Claiborne's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Cary J Claiborne has 0.
Where does Cary J Claiborne file Form 4?
Cary J Claiborne has filed Form 4 at ADIL (ADIAL PHARMACEUTICALS, INC.) as Chief Executive Officer. A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.